[INTRODUCTION 1 PART I 2 Item 1. Identity of Directors, Senior Management and Advisers 2 Item 2. Offer Statistics and Expected Timetable 2 Item 3. Key Information 2 Item 4. Information on the Company 40 Item 4A. Unresolved Staff Comments 65 Item 5. Operating and Financial Review and Prospects 65 Item]
[CHINA AUTOMOTIVE SYSTEMS, INC. FORM 10-K INDEX Page PART I 4 Item 1. Business. 4] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No.333-126959) of China Automotive Systems, Inc. of our report da]
[INTRODUCTION 1 PART I 2 Item 1. Identity of Directors, Senior Management and Advisers 2 Item 2. Offer Statistics and Expected Timetable 2 Item 3. Key Information 2 Item 4. Information on the Company 40 Item 4A. Unresolved Staff Comments 65 Item 5. Operating and Financial Review and Prospects 65 Item]
[This Form 6-K consists of: 1. 2. 3. 4. Document 1 CONTENTS 2 Company Profile 3 Principal Financial Data and Indicators 6 Changes in Share Capital and Shareholdings of Principal Shareholders 8 Chairman’s Address 11 Business Review and Prospects 19 Management’s Discussion and Analysis 31 Significant E]
[This Form 6-K consists of: 1. 2. 3. 4. Document 1 CONTENTS 2 Company Profile 3 Principal Financial Data and Indicators 6 Changes in Share Capital and Shareholdings of Principal Shareholders 8 Chairman’s Address 11 Business Review and Prospects 19 Management’s Discussion and Analysis 31 Significant E]
[] [December 5, 2018 Dear Ms. Heung Mei Tsui On behalf of the Board of Directions and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc as a director. The compensation is $16,000 per year. I look forward to working with you. Your appointment date is December]
[China Automotive Systems Reports Fourth Quarter and Fiscal 2018 Results WUHAN, China, March 28, 2019 China Automotive Systems, Inc. (NASDAQ: CAAS) Fourth Quarter 2018 Highlights · Net sales were $124.3 million compared to $143.7 million in the fourth quarter of 2017 · Net loss attributable to parent]
[] [December 5, 2018 Dear Ms. Heung Mei Tsui On behalf of the Board of Directions and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc as a director. The compensation is $16,000 per year. I look forward to working with you. Your appointment date is December]
[China Automotive Systems Reports Fourth Quarter and Fiscal 2018 Results WUHAN, China, March 28, 2019 China Automotive Systems, Inc. (NASDAQ: CAAS) Fourth Quarter 2018 Highlights · Net sales were $124.3 million compared to $143.7 million in the fourth quarter of 2017 · Net loss attributable to parent]
[2018 Corporate Social Responsibility Report of China Life Contents Message from Chairman 1 About Us 3 (I) Company Profile 3 (II) Corporate Culture 4 (III) Honors 5 Corporate Governance 7 Risk Management and Compliance 9] [001-31914 20-F Description 99.1 Announcement, dated March 27, 2019 001-31914 C]
